Indivior Pharmaceuticals Earnings
NASDAQ: INDVHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Thu, Oct 29, 2026
Fiscal period
Sep/2026
EPS estimate
$0.93
Indivior Pharmaceuticals earnings summary
Indivior Pharmaceuticals is scheduled to report Sep/2026 earnings on Oct 29, 2026, with analysts expecting EPS of $0.93. In its most recent report on Aug 3, 2026 (Q2 2026), INDV posted EPS of $0.98. Revenue for the quarter was $343.0 million.
Quarterly EPS is up 600.0% from the same quarter a year earlier. Across the last 7 reports, INDV shares moved an average of 3.7% (in either direction) in the first trading session after results, rising 4 times and falling 3 times.
Summary generated from market data by MetaCap's automated system. Methodology
INDV earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 3, 2026 | — | $0.98 | — | +0.5% |
| Apr 30, 2026 | — | $0.69 | — | +4.9% |
| Feb 26, 2026 | — | $0.79 | — | -1.4% |
| Oct 30, 2025 | — | $0.33 | — | +6.7% |
| Jul 31, 2025 | — | $0.14 | — | +4.5% |
| May 1, 2025 | — | $0.38 | — | -7.5% |
| Mar 3, 2025 | — | $0.16 | — | -0.2% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.